M

Medsol Clinical Research Center | Port Charlotte, FL

Research site
(Unclaimed)
Location
Harbor Professional Centre 3390 Tamiami Trail, Unit 205, Port Charlotte, Florida, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 22
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain

To be eligible for the trial, subjects must have ongoing moderate to severe neuropathic pain related to a prior course of platinum and/or taxane chem...

Enrolling
Chemotherapy-induced Peripheral Neuropathy
Chemotherapy-induced Neuropathic Pain
Drug: Placebo
Drug: Tetrodotoxin

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravi...

Enrolling
Myasthenia Gravis
Drug: Placebo
Drug: Nipocalimab

The main aim is to assess the long-term safety and tolerability of soticlestat when used along with other anti-seizure treatment.Participants will re...

Active, not recruiting
Dravet Syndrome (DS)
Epilepsy
Drug: Soticlestat

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Enrolling
Focal Epilepsy
Drug: BHV-7000
Drug: Placebo

The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and toler...

Active, not recruiting
Focal Epilepsy
Drug: XEN1101

The primary objective is:To evaluate the effect of pozelimab + cemdisiran on daily functioning that is impacted by signs and symptoms in patients wit...

Enrolling
Generalized Myasthenia Gravis
Drug: Pozelimab + Cemdisiran
Drug: Pozelimab

The purpose of this clinical trial is to compare the efficacy of twice daily applications of ATX01 (10% & 15%) versus placebo during a 12-week treatm...

Enrolling
Chemotherapy-induced Peripheral Neuropathy
Drug: ATX01 15%
Drug: ATX01 10%

This study consists of 2 parts. Part 1 of the study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to...

Active, not recruiting
Early Parkinson Disease
Other: placebo
Drug: K0706

Trial conditions

Epilepsy (9 trials)
Seizures (6 trials)
Partial Epilepsies (5 trials)
Muscle Weakness (3 trials)
Myasthenia Gravis (3 trials)
Peripheral Nervous Syste... (3 trials)
Diabetes Mellitus (2 trials)
Neuralgia (2 trials)
Type 2 Diabetes Mellitus (2 trials)
Bacterial Conjunctivitis (1 trial)

And 7 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems